Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Asia is shaping up to be a vaccine powerhouse. The signs are there in funding levels, and combined with Asian governments’ interest in biotechnology, and a highly skilled, highly educated workforce, pharma giants are looking east.
This advertisement feature is produced by Nature Research Custom Media in partnership with the National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN). The advertiser retains responsibility for content. About this content.
Integrating basic and clinical research is key to the development of safe and effective mucosal vaccines taken orally or nasally, says Hiroshi Kiyono of the Institute of Medical Science, the University of Tokyo.